4.7 (592) In stock
Researchers from the University of Edinburgh and the Spanish National Research Council have harnessed the power of artificial intelligence (AI) to discover three potent molecules that could potentially slow down the ageing process. The study, led by Integrated Biosciences, a biotechnology company dedicated to ageing research, demonstrates the tremendous potential of AI in uncovering novel senolytic compounds capable of suppressing age-related processes such as fibrosis, inflammation, and cancer.
Reprogramming iPSCs to study age-related diseases: Models, therapeutics, and clinical trials - ScienceDirect
Anti-ageing drugs are coming that could keep you healthier for longer
Identifying molecular targets for reverse aging using integrated network analysis of transcriptomic and epigenomic changes during aging
AI revolutionises ageing research: Promising anti-aging compounds discovered - The Week
Artificial intelligence identifies new anti-aging compounds •
AI revolutionises ageing research: Promising anti-aging compounds discovered - The Week
72 Unlocking the Future: AI-Powered Breakthroughs in Anti-Aging Medicine
AI Revolutionises Anti-Aging Research: Uncovering Natural Compounds to Slow Aging Process
AI projects in Europe – How is Artificial Intelligence Changing Science?
AI identifies three new antiaging senolytic candidates
How AI is transforming InsurTech - FinTech Global
A win-win for cell communities: Cells that cooperate live longer - New insights into the study of aging processes and age-related diseases
Electronics, Free Full-Text
